Pharmacological Mechanisms of Kirenol against Ovarian Carcinoma: A Network Pharmacology and Experimental Validation Study In Vitro
CONCLUSION: In summary, the combined results of our network pharmacology analysis and in vitro tests emphasized that Kirenol hinders the growth of ovarian cancer cells, causes cell cycle arrest, enhances apoptosis, and hampers migration, possibly by regulating the PI3K/AKT/CDK4 signaling pathway.PMID:38415456 | DOI:10.2174/0113862073289977240216075724
Source: Combinatorial Chemistry and High Throughput Screening - Category: Chemistry Authors: Xiaoling Mao Hong Zhu Jun Gao Shixin Lin Yin Bao Mingyue Zhang Huan Yang Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemistry | Drugs & Pharmacology | Epithelial Cancer | Genetics | Ovarian Cancer | Ovaries | Study